Skip to main content

Day: July 22, 2024

Banking Transformation Expert David Schiff Joins FTI Consulting

WASHINGTON, July 22, 2024 (GLOBE NEWSWIRE) — FTI Consulting, Inc. (NYSE: FCN) today announced the appointment of David Schiff as a Senior Managing Director in the Financial Services practice within the firm’s Corporate Finance & Restructuring segment. Mr. Schiff, who is based in Los Angeles, joins with more than 20 years of experience in conceiving, designing and executing transformational initiatives across the financial services industry. In his role at FTI Consulting, Mr. Schiff will have a special focus on working with regional and super-regional bank leadership and client-facing teams to materially enhance performance by improving growth, optimizing operations and enhancing customer and enterprise value. “The financial services industry is facing economic and regulatory pressures not seen in decades that are transforming...

Continue reading

MariMed Commences Operations In Newly Expanded Area of Maryland Cultivation Facility

Seedlings Planed in New Grow Rooms, In Time for Retail and Wholesale Distribution of Products During Fourth Quarter of 2024 NORWOOD, Mass., July 22, 2024 (GLOBE NEWSWIRE) — MariMed Inc. (“MariMed,” “the Company”) (CSE: MRMD) (OTCQX: MRMD), a leading multi-state cannabis operator focused on improving lives every day, today announced it recently commenced operations in the newly expanded area of its cultivation and processing facility in Hagerstown, Maryland. The expansion will double the facility’s flower capacity, enabling MariMed to meet the growing demand for its flower, concentrates, and edibles products in the state. MariMed is on track to fill all nine new grow rooms with new plantings over the next two months. The Company anticipates its first harvest will be ready for sale through both retail and wholesale channels during...

Continue reading

Hamilton Thorne Announces Agreement to be Acquired by Astorg for CAD$2.25 Per Share in Cash

Purchase price of CAD$2.25 per Hamilton Thorne share represents enterprise value of approximately CAD$388 million (US$282 million). Represents a premium of approximately 54% to the closing price on the Toronto Stock Exchange (“TSX”) of Hamilton Thorne shares on July 19, 2024, the last trading day prior to the announcement of the transaction, and approximately 62% to the 90-day VWAP as of the same date1. The Board of Directors of Hamilton Thorne (with interested directors abstaining) unanimously determined that the transaction is in the best interests of Hamilton Thorne and the transaction consideration to be received by the Hamilton Thorne shareholders is fair, from a financial point of view.BEVERLY, Mass. and TORONTO, July 22, 2024 (GLOBE NEWSWIRE) — Hamilton Thorne Ltd (TSX: HTL) (“Hamilton Thorne” or the “Company”), a leading...

Continue reading

Manhattan Bridge Capital, Inc. Reports Second Quarter 2024 Results

GREAT NECK, N.Y., July 22, 2024 (GLOBE NEWSWIRE) — Manhattan Bridge Capital, Inc. (Nasdaq: LOAN) (the “Company”) announced today that its total revenues for the three months ended June 30, 2024 were approximately $2,443,000 compared to approximately $2,399,000 for the three months ended June 30, 2023, an increase of $44,000, or 1.8%. The increase in revenue was due to higher interest rates charged on the Company’s commercial loans, partially offset by a reduction in loans receivable, period over period, and reduced origination fees, which were impacted by a slowdown in new loan originations. For the three months ended June 30, 2024 and 2023, approximately $2,033,000 and $1,943,000, respectively, of the Company’s revenues were attributable to interest income on secured commercial loans that the Company offers to real estate investors,...

Continue reading

HBT Financial, Inc. Announces Second Quarter 2024 Financial Results

Second Quarter HighlightsNet income of $18.1 million, or $0.57 per diluted share; return on average assets (“ROAA”) of 1.45%; return on average stockholders’ equity (“ROAE”) of 14.48%; and return on average tangible common equity (“ROATCE”)(1) of 17.21% Adjusted net income(1) of $18.1 million; or $0.57 per diluted share; adjusted ROAA(1) of 1.45%; adjusted ROAE(1) of 14.54%; and adjusted ROATCE(1) of 17.27% Asset quality remained strong with nonperforming assets to total assets of 0.17%, close to a historic low Net interest margin and net interest margin (tax-equivalent basis)(1) increased slightly to 3.95% and 4.00%, respectivelyBLOOMINGTON, Ill., July 22, 2024 (GLOBE NEWSWIRE) — HBT Financial, Inc. (NASDAQ: HBT) (the “Company” or “HBT Financial” or “HBT”), the holding company for Heartland Bank and Trust Company, today...

Continue reading

Southern States Bancshares, Inc. Announces Second Quarter 2024 Financial Results

Second Quarter 2024 Performance and Operational HighlightsNet income of $8.2 million, or $0.90 per diluted share Core net income(1) of $9.1 million, or $1.00 per diluted share(1) Net interest income of $21.6 million, an increase of $740,000 from the prior quarter Net interest margin (“NIM”) of 3.56%, down 3 basis points from the prior quarter NIM of 3.57% on a fully-taxable equivalent basis (“NIM – FTE”)(1) Return on average assets (“ROAA”) of 1.29%; return on average stockholders’ equity (“ROAE”) of 14.55%; and return on average tangible common equity (“ROATCE”)(1) of 15.79% Core ROAA(1) of 1.43%; and core ROATCE(1) of 17.44% Efficiency ratio of 49.78%; and core efficiency ratio of 44.75% Linked-quarter loans grew 10.3% annualized Linked-quarter total deposits grew 12.6% annualized Linked-quarter total deposits, excluding brokered...

Continue reading

BioCryst to Report Second Quarter 2024 Financial Results on August 5

RESEARCH TRIANGLE PARK, N.C., July 22, 2024 (GLOBE NEWSWIRE) — BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the company will report its second quarter 2024 financial results on Monday, August 5, 2024. BioCryst management will host a conference call and webcast at 8:30 a.m. ET that day to discuss the financial results and provide a corporate update. The live call may be accessed by dialing 1-844-481-2942 for domestic callers and 1-412-317-1866 for international callers. A live webcast and replay of the call will be available online in the investors section of the company website at www.biocryst.com. About BioCryst Pharmaceuticals BioCryst Pharmaceuticals is a global biotechnology company with a deep commitment to improving the lives of people living with complement-mediated and other rare diseases. BioCryst...

Continue reading

Virtu Triton Wins Best Equity E/OMS at European Markets Choice Awards 2024

NEW YORK, July 22, 2024 (GLOBE NEWSWIRE) — Virtu Financial, Inc. (Nasdaq:VIRT), a leading provider of global, multi-asset financial services that delivers liquidity and innovative, transparent products across the complete investment cycle to the global markets, today announced that Virtu’s Triton Valor EMS was awarded best Equity E/OMS at Market Media’s European Markets Choice Awards 2024. Triton is a global, multi-asset execution management system for trading equities, ETFs, futures, options, FX and fixed income across 700+ brokers and venues for all types of flow–Care, PT, DMA, Algos, RFS and RFQs. Triton was designed with an active trader in mind and provides technology that assists traders achieving their objectives throughout the lifecycle of a trade. In response to heightened European client demand, Triton has notably expanded...

Continue reading

OTC Markets Group Welcomes Cullman Bancorp, Inc. to OTCQX

NEW YORK, July 22, 2024 (GLOBE NEWSWIRE) — OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced Cullman Bancorp, Inc. (OTCQX: CULL), the holding company for Cullman Savings Bank, has qualified to trade on the OTCQX® Best Market. Cullman Bancorp, Inc. previously traded on NASDAQ. Cullman Bancorp, Inc. begins trading today on OTCQX under the symbol “CULL.” U.S. investors can find current financial disclosure and Real-Time Level 2 quotes for the company on www.otcmarkets.com. Trading on the OTCQX Market offers companies efficient, cost-effective access to the U.S. capital markets. Streamlined market requirements for OTCQX are designed to help companies lower the cost and complexity of being publicly traded, while providing transparent trading for...

Continue reading

Ero Copper and Vale Base Metals Execute Definitive Earn-In Agreement on the Furnas Copper Project

VANCOUVER, British Columbia, July 22, 2024 (GLOBE NEWSWIRE) — Ero Copper Corp. (TSX: ERO, NYSE: ERO) (“Ero” or the “Company”) is pleased to announce that it has signed a definitive earn-in agreement (“Agreement”) with Salobo Metais S.A, a subsidiary of Vale Base Metals Limited (“VBM”), to earn a 60% interest in the Furnas Copper Project (“Furnas” or the “Project”) located in the Carajás Mineral Province in Pará State, Brazil. The terms of the Agreement align with the previously signed binding term sheet outlined in the Company’s press release dated October 30, 2023. For additional detail on the Project, including location maps, geologic cross sections, historical drill intercepts and a description of the Company’s work programs, please refer to the Company’s...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.